Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Prestige Consumer Healthcare (PBH) Divestments (2016)

Prestige Consumer Healthcare has reported Divestments over the past 1 years, most recently at $48.4 million for Q4 2016.

For Q4 2016, Divestments changed N/A year-over-year to $48.4 million; the TTM value through Mar 2017 reached $48.4 million, changed N/A, while the annual FY2019 figure was $65.9 million, N/A changed from the prior year.
Divestments for Q4 2016 was $48.4 million at Prestige Consumer Healthcare.
Over five years, Divestments peaked at $48.4 million in Q4 2016 and troughed at $48.4 million in Q4 2016.